OCT is a full service clinical research organization in the USA. OCT has become a reliable partner for numerous companies around the world, including the USA.
OCT provides end-to-end services for phases I-IV clinical research programs and delivers high quality research data in full compliance with ICH GCP principles. Our advantage lies in our ability to guide and partner with our clients, tailoring clinical trial settings, using the benefits of cost savings and efficiencies that can be achieved through involvement of Russia, Ukraine, Belarus and other countries in Central and Eastern Europe, while maintaining the highest FDA and EMA Standards.
OCT’s strategy is to generate FDA and EMA-acceptable data by including most of the subjects in our studies in the EEU region, the USA and Europe. Such approach ensures the most optimal combination of fast reliable enrollment and low costs of studies by OCT. During 11 years of operation, OCT has become the leading CRO in the region and have successfully completed over 200 phase I-IV projects in different indications.